The distributor sells $420M a year from 40 manufacturers through 110 territory managers, 24 inside sales reps and 12 clinical specialists. New territory managers take 11 months to reach full quota and 31% leave in their first year. Five higher-margin categories bring in $76M, but only 28% of reps sell three or more of them in a quarter. Hospital value analysis committees approve 44% of our submissions. Reps build their own decks from 1,400 files on a shared drive, and an internal audit found that 42% of the files in use had no current regulatory approval.
Challenges- Onboarding is two weeks of manufacturer presentations followed by a territory handover. New hires learn products, not how a hospital buys.
- Reps are comfortable with surgeons and nurses but lose the financial argument with supply chain and value analysis, where conversions are decided.
- Unapproved, rep-edited material creates off-label promotion risk and wastes about five selling hours per rep each week.
We will focus on- Field territory managers and their 14 regional managers.
- Five priority categories: surgical visualization, patient monitoring, infection prevention, wound closure and orthopedic soft goods.
- The value analysis submission, from clinical trial to committee decision.
We will not- Training on all 40 manufacturer lines. Outside the five priority categories, reps rely on manufacturer in-services.
- Buying call recording software. Most selling happens inside hospitals where recording is not permitted, so observation stays with managers on ride-alongs.
- A branded sales methodology rollout. We will teach the committee and total-cost conversations our deals turn on.